#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Carcinoid tumour Craniopharyngioma MELAS syndrome Choroid melanoma Oesophageal achalasia Polyneuropathy Scleroderma associated digital ulcer Niemann-Pick disease Mucous membrane pemphigoid Conjunctivitis allergic Gaucher's disease type I Rhabdomyosarcoma recurrent Alveolar rhabdomyosarcoma Basal cell naevus syndrome Lymphoma More trials…

    Learn about Rare Diseases

    Brain stem glioma – Trials in Disease KBG syndrome – Trials in Disease Mantle cell lymphoma IgA nephropathy – Treatment Pleural mesothelioma malignant – Treatment Niemann-Pick disease – Diagnostics Piriformis syndrome – Treatment Pulmonary sarcoidosis – Life with Disease Leukoencephalopathy – Basic Information Urea cycle disorder – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carvedilol Benfotiamine Cevostamab Tirbanibulin Ro7790121 Methadone Hydrochloride Levonorgestrel Cx-037231 Ontasameran Lorundrostat DESMOPRESSIN ACETATE Zoledronic Acid Amy109 [89ZR]ZR-DFO-CIT-013 Pp1493 ACT-1004-1239 Indacaterol Sotalol Vsf1.01 Ertapenem More therapies…

    Learn about Your Condition

    Acute myeloid leukaemia Hyperparathyroidism primary Head injury Large cell lung cancer Anal abscess Bacterial vaginosis Labour induction Sepsis Periarthritis B-cell lymphoma Adrenal insufficiency Multiple sclerosis Myotonia Metachromatic leukodystrophy Renal cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Alergo Med Osrodek Badan Klinicznych Sp. z o.o.

Alergo Med Osrodek Badan Klinicznych Sp. z o.o.

Ul. Polskiego Czerwonego Krzyza 26, Tarnow, 33-100, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy and Safety of Inhaled Glycopyrronium Bromide Added to Budesonide and Formoterol Fumarate in Children 4‑12 Years with Asthma (Placebo‑Controlled)

    Recruiting

    2 1
    Investigated Drugs:
    • Formoterol Fumarate
    • Budesonide
    • Glycopyrronium Bromide
    Czechia Hungary Poland

  • Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

    Recruiting

    3 1 1
    Investigated Drugs:
    • Indacaterol Acetate
    • Mometasone Furoate
    • Salmeterol
    France Germany Hungary Poland Romania Slovakia +1

  • A study to evaluate the efficacy and safety of lesigercept in adults with chronic spontaneous urticaria who do not have enough relief from antihistamines

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Bulgaria Poland

  • A study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cold urticaria
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Germany Lithuania Poland Spain

  • Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Beclometasone Dipropionate
    • Formoterol Fumarate Dihydrate
    Bulgaria Czechia Germany Hungary Latvia Poland +2

  • Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

    Recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • 12 Grass Pollen Mixture
    • Desloratadine
    • Grass Pollen Allergen Extract Modified With Glutaraldehyde And Adsorbed To L-Tyrosine
    Bulgaria Czechia Germany Lithuania Poland Romania +1

  • A Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Bulgaria Poland

  • A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Belgium Bulgaria Croatia Czechia Denmark France +10

  • Pharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Nemolizumab
    Poland

  • Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Img-007
    Czechia Germany Hungary Poland Spain
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!